Bauerfeind Holding GmbH – Trademark Portfolio

Entity Type: 16

Bauerfeind Holding GmbH holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include AIRLOC, SECUTEC, and LORDOLOC. The owner is based in 07937 Zeulenroda.

Weissendorfer Strasse 5

07937 Zeulenroda , DE

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SECUTEC
SECUTEC
Registered 2002
BRAINTEC
BRAINTEC
Cancelled 2002
AIRLOC
AIRLOC
Registered 2002
DORSOLOC
DORSOLOC
Cancelled 2002
LORDOLOC
LORDOLOC
Registered 2002
CLAVILOC
CLAVILOC
Abandoned 2000
EXERSOX
EXERSOX
Cancelled 2000

Trademark Classifications

Bauerfeind Holding GmbH's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Bauerfeind Holding GmbH have?

Bauerfeind Holding GmbH has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 3 cancelled.

What trademark classes does Bauerfeind Holding GmbH file in?

Bauerfeind Holding GmbH files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Bauerfeind Holding GmbH's most well-known trademarks?

Bauerfeind Holding GmbH's registered trademark portfolio includes well-known marks such as AIRLOC, SECUTEC, and LORDOLOC. These are among 3 currently registered trademarks in the portfolio.

What is Bauerfeind Holding GmbH's trademark registration success rate?

Bauerfeind Holding GmbH has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.